Navigation Links
NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment
Date:11/20/2009

NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN Clinical Practice Guidelines in Oncology(TM) for Breast Cancer to determine an individualized treatment regimen. The program, which provides free CME credits, premieres on Sunday, November 22 at 7:00 am EST.

FORT WASHINGTON, Pa., Nov. 20 /PRNewswire-USNewswire/ -- Although October (National Breast Cancer Awareness Month) is behind us, it remains imperative for both physicians and patients to keep up-to-date on the latest treatment developments for breast cancer, as well as all types of cancer. Metastatic breast cancer is breast cancer that has spread beyond the breast into places such as the bones, lungs, liver, or brain. Although metastatic breast cancer is not curable, there are many effective treatments, including a number of recent treatment advances that are enabling women with metastatic breast cancer to live longer and better lives. However, treatment needs to be highly individualized as no single treatment plan is right for everyone.

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, has collaborated with the Discovery Health Channel to produce a program profiling three patients with metastatic breast cancer and their healthcare team as they customize each patient's treatment regimen to their individual tumor type and health status. The program, Metastatic Breast Cancer: Individualizing Treatment, premieres Sunday, November 22, 2009 at 7 am EST on the Discovery Health Channel. This program is available for Continuing Medical Education (CME/CE) credits for physicians as well as nurses.

"Discovery Health is thrilled to continue its ongoing partnership with the National Comprehensive Cancer Network and the launch of this incredibly valuable and timely program," said John Whyte, MD, Vice President, Continuing Medical Education and Chief Medical Expert, Discovery Health. "This collaboration directly aligns with Discovery Health's mission to deliver credible, high-quality Continuing Medical Education content to physicians and health care providers."

NCCN is known for developing the NCCN Clinical Practice Guidelines in Oncology(TM), a leading clinical reference for health care providers around the globe. This program will include members of the NCCN Guidelines Panel for Breast Cancer as they explore individualizing treatment for patients with metastatic breast cancer and focus on evolving data for the disease and the application in the current NCCN Guidelines.

Featured faculty includes:

  • William J. Gradishar, MD - Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Beryl McCormick, MD - Memorial Sloan-Kettering Cancer Center
  • John H. Ward, MD - Huntsman Cancer Institute at the University of Utah

Current air dates for Metastatic Breast Cancer: Individualizing Treatment, please check your local listings for the most current schedule (all times are EST):

  • Sunday, November 22 - 7:00 am (premiere)
  • Saturday, November 28 - 7:00 am
  • Sunday, November 29 - 6:00 am
  • Sunday, December 6 - 6:00 am
  • Saturday, December 12 - 7:00 am
  • Sunday, December 27 - 6:00 am

For additional information about the program and available CME/CE credits, visit NCCN.org or DiscoveryHealthCME.com.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas

M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN. For more information, visit NCCN.org.

About Discovery Health CME:

Discovery Health CME (Continuing Medical Education) offers an entirely new way to learn about the latest advances in medicine. Medical professional are eligible to receive CME credits for viewing METASTIC BREAST CANCER: INDIVIDUALIZING TREATMENT. More information is available at DiscoveryHealthCME.com.

SOURCE National Comprehensive Cancer Network


'/>"/>
SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. AHCA Emphasizes Quality Improvement in Americas Nursing Homes
3. Photos: Georgia Pecan Campaign Emphasizes Nutritional Importance of Breakfast
4. As Chairman Baucus Outlines Vision for Healthcare Reform, NACDS Emphasizes Pharmacy's Essential Role in Any Successful Overhaul
5. American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage
6. PA Education Secretary Emphasizes Importance of Breakfast for Student Performance
7. Milliman Care Guidelines(R) 2009 Release Emphasizes Efficiency, Quality Solutions
8. American Society for Microbiology Emphasizes Hand Hygiene as Flu Protective Measure
9. New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform
10. OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures
11. New AMA Ad Emphasizes Common Ground on Health Reform, Shares Vision to Fix Broken System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: